Clinical Trials › NCT06800404
Active, Not RecruitingPhase 2
HB-adMSCs for the Treatment of Patients With Multiple Sclerosis
Sponsored by Hope Biosciences Research Foundation
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 10
Target enrollment
1
U.S. states
May 2025
Start date
Jan 2027
Expected completion
Interventions / Treatments
Autologous HB-adMSCs
Conditions studied
Relapsing Remitting Multiple Sclerosis (RRMS)Multiple Sclerosis
Where this trial is running (1 site)
Texas1 site
Sugar Land
MS centers in Texas
Compare treatment centers near a trial site — patient experience, providers, and care ratings.
View Texas centersMore Phase 2 trials
Browse all Phase 2 MS trialsCheck out the MS Buddy App
Track symptoms, monitor wellness, and stay on top of your MS care. It's free, no ads. How? It's made and supported by MS patients who get their ideas from other MS patients.
